Related Experiment Video

Updated: Mar 15, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

S Harrow1, G G Hanna2, C Faivre-Finn3

  • 1Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|September 4, 2016
PubMed

Insights

Combining novel agents with radiotherapy offers a potential new strategy for treating lung cancer, the most common cancer in the UK. This discussion explores key considerations and solutions for integrating these treatments in clinical studies.

Area of Science:

  • Oncology
  • Radiotherapy
  • Pharmacology

Background:

  • Lung cancer is the leading cancer diagnosis in the UK, with persistently poor patient outcomes.
  • There is a critical need for innovative treatment strategies to improve lung cancer survival rates.

Purpose of the Study:

  • To discuss critical issues and potential solutions for combining novel therapeutic agents with radiotherapy in clinical settings.
  • To provide insights from a Clinical Translational Radiotherapy Group (CTRad) workshop on optimizing combination therapies.

Main Methods:

  • Literature review and expert discussion synthesis.
  • Analysis of challenges in combining novel agents with radiotherapy.

Main Results:

  • Identification of key challenges in clinical trial design and drug-radiotherapy interaction.
  • Proposing potential strategies to mitigate risks and enhance efficacy.

Conclusions:

  • Combining novel agents with radiotherapy is a promising avenue for lung cancer treatment.
  • Careful consideration of logistical and biological factors is essential for successful clinical implementation.
Keywords:
DNA damage repairNSCLCimmunotherapyradiotherapyumbrella study

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K